About this trial
Primarily, This study aims to compare between interscalene block alone versus combined with superior truncus block in producing diaphragmatic paralysis and Secondarily aims to evaluate
1. Effect on the pulmonary function. 2. Duration of the sensory and motor block. 3. Postoperative analgesic consumption. 4. Any complications or side effects during shoulder surgery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
ASA (American Society of Anesthesiologists) I, II physical status.
Aged between 20 and 65 years.
Male or female.
Body Mass index (BMI): 18-30 kg/m3.
Disqualifiers
Allergy to local anesthetics.
Infection at the injection site.
Coagulation disorders.
Respiratory diseases ( Acute or Chronic) or Chest trauma.
Trial design
Parallel
Treatments tested in this trial
Regional anesthesia in shoulder surgery
Other interventionComparison of the interscalene block alone versus combined with superior truncus block during shoulder surgery in diaphragmatic function
Treatment groups
Trial outcomes
Primary outcomes
Comparison between interscalene block alone versus combined with superior truncus block inproducing diaphragmatic paralysis
Assessment of diaphragmatic function by diaphragm excursion (DE) and diaphragm thickening fraction (TF) will be measured both before and 30 minutes post-block. To measure DE, patients will be placed in a supine position, a convex transducer (3.5 \~ 5 MHz) will be used to scan while the right diaphragm through the hepatic window and the left diaphragm through the splenic window, which located near the anterior-axillary line. The craniocaudal movement of the diaphragm will be documented during deep inspiration using M-mode. * Complete diaphragmatic paralysis was defined as a 75% \~ 100% reduction in DE, including the occurrence of paradoxical movement. * Partial diaphragmatic paralysis was defined as a 25% \~ 75% reduction in DE. * No diaphragmatic paralysis was indicated by a DE reduction of less than 25%. To measure TF, patients will be placed in the same position with the head of the bed at 45°degree
Secondary outcomes
Evaluation of the interscalene block alone versus combined with superior truncus block during shoulder surgery on the pulmonary function
Assessment of pulmonary function by a handheld spirometer to measure forced vital capacity (FVC), forced expiratory volume ( FEV1, FEV2) with patients in an upright-seated position pre-block and 30 minutes post-block as well as 2-hours post-surgery. Spirometry will be performed three times, with the best effort recorded.
Duration of the sensory and motor block onset, duration of the interscalene block alone versus combined with superior truncus block during shoulder surgery
Sensory block onset time will be assessed at the time from local anesthetics injection by pinprick test which will be preformed with 22-gauge short beveled needle every minute. Sensory block recovery time will be noted every hour in 1st 6 hours, every 2 hours in 2nd 6 hours till recovery of all pain sensation in all dermatomes performed by pinprick test. Motor block onset time will be assessed at the time from local anesthetics injection until complete motor block which will be assessed by absence of voluntary movement on asking the patient to elevate his arm every minute. Motor block recovery time will be noted as the time of return of voluntary movement in the arm every hour in 1st 6 hours, every 2 hours in 2nd 6 hours.
Evaluation of postoperative analgesic consumption
Pain will be evaluated Postoperative immediately every hour in 1st 6 hours, every 2 hours in 2nd 6 hours by Visual Analogue Scale ( VAS) by instructing the patient to point to the position on the line to indicate how much pain they are currently feeling(10). * VAS (zero) indicates no pain. * VAS ( 1, 2, 3) indicates mild pain. * VAS ( 4, 5, 6) indicates moderate pain. * VAS ( 7, 8, 9, 10) : indicates severe pain.
Evaluation of any complications or side effects during shoulder surgery
Any local or systemic complications or side effects will be recorded every 2 hours post operative for 24 hours such as local anesthetic systemic toxicity (LAST), Horner's syndrome, hypoxia, dyspnea, pneumothorax and post-operative nausea and vomiting (PONV).
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: